Lincoject 10 % w/v Solution for Injection

Active Substance:
Lincomycin 10.0% w/v [100 mg/ml]
(as Lincomycin hydrochloride 11.34% w/v [113.4 mg/ml])

Indications for use, specifying the target species:

In dogs and cats, Lincoject is recommended for the treatment of infections caused by Lincomycin susceptible Gram-positive organisms, particularly streptococci and staphylococci and certain Gram-negative anaerobic bacteria (e.g. Bacteroides, Fusobacterium species).

Lincoject is recommended for treatment of the following conditions in dogs and cats: Tonsillitis, laryngitis and other respiratory tract infections; abscesses, infected wounds and purulent dermatitis; septicaemia.

In pigs, Lincoject is indicated for the treatment of infections caused by Lincomycin susceptible Gram-positive organisms (e.g. staphylococci, streptococci), certain Gram-negative anaerobic organisms (e.g. Serpulina (Treponema) hyodysenteriae, Bacteroids, Fusobacterium and Mycoplasma species).

Lincoject is recommended for treatment of the following conditions in pigs: Swine dysentry, enzootic or mycoplasmal pneumonia, septic arthritis, foot abscesses.